Siemens N Antisera to Human Apolipoprotein A-II and Apolipoprotein E - HSA Registration DE0018388
Access comprehensive regulatory information for Siemens N Antisera to Human Apolipoprotein A-II and Apolipoprotein E in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0018388 and owned by Siemens Healthcare Diagnostics Products GmbH. The device was registered on July 20, 2016.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
N APOAII is an in vitro diagnostic reagent for the quantitative IFCC-standardized determination of apolipoprotein A-II (Apo A-II) as an aid in the assessment of high-density lipoprotein (HDL) metabolism defects related to cardiovascular disease and arteriosclerosis in human serum by means of automated Siemens Healthineers immuno- nephelometry systems. N APOE is an in vitro diagnostic reagent for the quantitative determination of apolipoprotein E (Apo E) in human serum as an aid to diagnosis for congenital hyperlipoproteinemia by means of automated Siemens Healthineers immuno-nephelometry systems.